Literature DB >> 10786835

Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine.

C Scheufler1, A Brinker, G Bourenkov, S Pegoraro, L Moroder, H Bartunik, F U Hartl, I Moarefi.   

Abstract

The adaptor protein Hop mediates the association of the molecular chaperones Hsp70 and Hsp90. The TPR1 domain of Hop specifically recognizes the C-terminal heptapeptide of Hsp70 while the TPR2A domain binds the C-terminal pentapeptide of Hsp90. Both sequences end with the motif EEVD. The crystal structures of the TPR-peptide complexes show the peptides in an extended conformation, spanning a groove in the TPR domains. Peptide binding is mediated by electrostatic interactions with the EEVD motif, with the C-terminal aspartate acting as a two-carboxylate anchor, and by hydrophobic interactions with residues upstream of EEVD. The hydrophobic contacts with the peptide are critical for specificity. These results explain how TPR domains participate in the ordered assembly of Hsp70-Hsp90 multichaperone complexes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10786835     DOI: 10.1016/S0092-8674(00)80830-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  464 in total

1.  The hsp90 chaperone complex regulates intracellular localization of the dioxin receptor.

Authors:  A Kazlauskas; S Sundström; L Poellinger; I Pongratz
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Proteins of the endoplasmic-reticulum-associated degradation pathway: domain detection and function prediction.

Authors:  C P Ponting
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

3.  Polypeptide release by Hsp90 involves ATP hydrolysis and is enhanced by the co-chaperone p23.

Authors:  J C Young; F U Hartl
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 4.  From the cradle to the grave: molecular chaperones that may choose between folding and degradation.

Authors:  J Höhfeld; D M Cyr; C Patterson
Journal:  EMBO Rep       Date:  2001-10       Impact factor: 8.807

5.  Hsp90 reaches new heights. Conference on the Hsp90 chaperone machine.

Authors:  Avrom J Caplan; Sophie Jackson; David Smith
Journal:  EMBO Rep       Date:  2003-02       Impact factor: 8.807

6.  The molecular chaperone Hsp70 activates protein phosphatase 5 (PP5) by binding the tetratricopeptide repeat (TPR) domain.

Authors:  Jamie N Connarn; Victoria A Assimon; Rebecca A Reed; Eric Tse; Daniel R Southworth; Erik R P Zuiderweg; Jason E Gestwicki; Duxin Sun
Journal:  J Biol Chem       Date:  2013-12-10       Impact factor: 5.157

Review 7.  New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential.

Authors:  Yanyan Li; Tao Zhang; Steven J Schwartz; Duxin Sun
Journal:  Drug Resist Updat       Date:  2009 Feb-Apr       Impact factor: 18.500

8.  Alteration of the protein kinase binding domain enhances function of the Saccharomyces cerevisiae molecular chaperone Cdc37.

Authors:  Min Ren; Arti Santhanam; Paul Lee; Avrom Caplan; Stephen Garrett
Journal:  Eukaryot Cell       Date:  2007-06-15

9.  Molecular basis for TPR domain-mediated regulation of protein phosphatase 5.

Authors:  Jing Yang; S Mark Roe; Matthew J Cliff; Mark A Williams; John E Ladbury; Patricia T W Cohen; David Barford
Journal:  EMBO J       Date:  2004-12-02       Impact factor: 11.598

10.  A gain-of-function mutation in the second tetratricopeptide repeat of TFIIIC131 relieves autoinhibition of Brf1 binding.

Authors:  Robyn D Moir; Karen V Puglia; Ian M Willis
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.